Form 8-K - Current report:
SEC Accession No. 0001193125-24-274395
Filing Date
2024-12-10
Accepted
2024-12-10 17:00:29
Documents
14
Period of Report
2024-12-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d919024d8k.htm   iXBRL 8-K 27015
2 EX-3.1 d919024dex31.htm EX-3.1 7737
  Complete submission text file 0001193125-24-274395.txt   160007

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20241209.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20241209_lab.xml EX-101.LAB 17981
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20241209_pre.xml EX-101.PRE 11283
16 EXTRACTED XBRL INSTANCE DOCUMENT d919024d8k_htm.xml XML 3692
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 241539243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)